日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment

更正：11q13.3染色体扩增相关的淋巴结转移是由miR-548k通过调节肿瘤微环境驱动的。

期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-026-02586-w
Zhang, Weimin; Hong, Ruoxi; Li, Lin; Wang, Yan; Du, Peina; Ou, Yunwei; Zhao, Zitong; Liu, Xuefeng; Xiao, Wenchang; Dong, Dezuo; Wu, Qingnan; Chen, Jie; Song, Yongmei; Zhan, Qimin
肿瘤
肿瘤微环境
肿瘤免疫
发表日期：2026
文献求助 收藏

Sex-biased associations between gut microbiota and hematologic toxicity of neoadjuvant chemoradiotherapy in locally advanced rectal cancer

局部晚期直肠癌新辅助放化疗血液毒性与肠道菌群的性别差异关联

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000004688
Sui, Xin; Shi, Chen; Song, Maxiaowei; Jiang, Wenyi; Li, Shuai; Geng, Jianhao; Xu, Jun; Zhang, Yangzi; Zhu, Xianggao; Cai, Yong; Li, Bo; Wang, Hongzhi; Dong, Dezuo; Teng, Huajing; Li, Yongheng; Wang, Weihu
肿瘤
肠癌
肿瘤免疫
微生物学
肠道菌群
毒理研究
发表日期：2026
文献求助 收藏

Neoadjuvant versus adjuvant radiotherapy for centrally located hepatocellular carcinoma: a propensity score matching study based on two prospective phase II trials

针对中央型肝细胞癌，新辅助放疗与辅助放疗的疗效比较：一项基于两项前瞻性 II 期试验的倾向评分匹配研究

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251342686
Wu, Fan; Chen, Bo; Dong, Dezuo; Wang, Liming; Wang, Hongzhi; Rong, Weiqi; Jin, Jing; Liu, Yueping; Fang, Hui; Tang, Yuan; Li, Yexiong; Wang, Weihu; Wu, Jianxiong
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Effectiveness and Safety of Systemic Therapy and Stereotactic Body Radiotherapy in Oligoprogressive and Oligometastatic Hepatocellular Carcinoma

系统治疗和立体定向放射治疗在寡转移性肝细胞癌中的有效性和安全性

期刊:Journal of Hepatocellular Carcinoma
影响因子:3.4
doi:10.2147/JHC.S519770
Song, Zhuo; Zheng, Xuan; Wang, Hongzhi; Dong, Dezuo; Zhu, Xianggao; Geng, Jianhao; Li, Shuai; Song, Maxiaowei; Du, Rongxu; Zhang, Yangzi; Liu, Zhiyan; Cai, Yong; Li, Yongheng; Wang, Weihu
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Planned Liver Stereotactic Body Radiotherapy for Residual Colorectal Cancer Liver Metastases After Surgery: A Single-Arm Retrospective Study

计划性肝脏立体定向放射治疗用于术后残余结直肠癌肝转移：一项单臂回顾性研究

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol32060347
Li, Sixuan; Dong, Dezuo; Zheng, Xuan; Wang, Hongzhi; Wang, Kun; Xing, Baocai; Wang, Weihu
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

4D-MRI assisted stereotactic body radiation therapy for unresectable colorectal cancer liver metastases

4D-MRI辅助立体定向放射治疗不可切除的结直肠癌肝转移

期刊:Clinical and Translational Radiation Oncology
影响因子:2.7
doi:10.1016/j.ctro.2023.100714
Wang, Hongzhi; Zheng, Xuan; Sun, Jiawen; Zhu, Xianggao; Dong, Dezuo; Du, Yi; Feng, Zhongsu; Gong, Jian; Wu, Hao; Geng, Jianhao; Li, Shuai; Song, Maxiaowei; Zhang, Yangzi; Liu, Zhiyan; Cai, Yong; Li, Yongheng; Wang, Weihu
肿瘤
肠癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Phase 2 Evaluation of Neoadjuvant Intensity-Modulated Radiotherapy in Centrally Located Hepatocellular Carcinoma: A Nonrandomized Controlled Trial

中心型肝细胞癌新辅助调强放射治疗的二期评估：一项非随机对照试验

期刊:Jama Surgery
影响因子:14.9
doi:10.1001/jamasurg.2022.4702
Wu, Fan; Chen, Bo; Dong, Dezuo; Rong, Weiqi; Wang, Hongzhi; Wang, Liming; Wang, Shulian; Jin, Jing; Song, Yongwen; Liu, Yueping; Fang, Hui; Tang, Yuan; Li, Ning; Zhu, Xianggao; Li, Yexiong; Wang, Weihu; Wu, Jianxiong
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma

阿帕替尼联合调强放射治疗治疗不可切除肝细胞癌的I期临床试验

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-022-09819-3
Wang, Hongzhi; Zhu, Xianggao; Zhao, Yuting; Dong, Dezuo; Li, Lijuan; Cai, Yong; Li, Yongheng; Wang, Weihu
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Nomogram to predict overall survival for patients with non-metastatic cervical esophageal cancer: a SEER-based population study

基于SEER数据库的人群研究：预测非转移性颈段食管癌患者总生存期的列线图

期刊:Annals of Translational Medicine
影响因子:
doi:10.21037/atm-20-2505
Dong, Dezuo; Zhao, Dan; Li, Shuai; Liu, Weixin; Du, Feng; Xu, Xiaolong; Xiao, Shaowen; Zheng, Baomin; Sun, Yan; Wang, Weihu
食管癌
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer

肺寡转移或结直肠癌寡转移进展患者的立体定向放射治疗预后因素及最佳反应间隔

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2019.01080
Li, Shuai; Dong, Dezuo; Geng, Jianhao; Zhu, Xianggao; Shi, Chen; Zhang, Yangzi; Wang, Hongzhi; Zhou, Shun; Wu, Hao; Cai, Yong; Li, Yongheng; Wang, Weihu
肠癌
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏